ALFA Finder| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 165.8 | 163.1 | 0.0 |
| Other income | 0.6 | 1.3 | 0.0 |
| Total income | 166.4 | 164.3 | 0.0 |
| Profit before exceptional items & tax | 12.5 | 11.4 | 0.0 |
| Profit before tax | 12.5 | 11.4 | 0.0 |
| Net profit | 8.2 | 8.4 | 0.0 |
| Operating margin | 7.5% | 6.9% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | -2.40% |
|---|
BSE results filing, BSE: 544611. Figures extracted from the filing.
Mahamaya Lifesciences Ltd: key numbers
- Share price
- ₹181.90
- Market cap
- ₹425.7 Cr
- Revenue (annual)
- ₹329.3 Cr
- Net profit (annual)
- ₹16.72 Cr
- P/E (TTM)
- 25.5×Sector 35.5×
- Promoter holding
- 56.39%
- FII holding
- 2.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mahamaya Lifesciences Ltd
All →Mahamaya Lifesciences Board Meeting Date
Mahamaya Lifesciences will hold a board meeting on November 13, 2026 to consider unaudited standalone and consolidated results for the half year ended September 30, 2026. The trading window stays closed until November 16, 2026.
Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd, an SME-platform listed company, confirms non-applicability of Corporate Governance under Regulation 27(2) for the quarter ended 30 September 2026. A Company Secretary certificate is enclosed.
Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Mahamaya Lifesciences Business Update
Mahamaya Lifesciences announced the publication of an executive interview in AgroPages Magazine (2026 India Focus Issue), highlighting operational progress and strategic growth initiatives.
Mahamaya Lifesciences Management Change
Mahamaya Lifesciences Limited announced management changes including the appointment of Dr. Bhagirath Choudhary and re-appointment of two Independent Directors. The MD and Executive Director were also re-designated.
Mahamaya Lifesciences Annual General Meeting
Mahamaya Lifesciences Limited held its 24th Annual General Meeting on September 29, 2026. Shareholders considered resolutions including financial statement adoption, director re-appointments, and management re-designations.